31 March 2021 : Laboratory Research
Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis
Xianfeng Zhang1A, Xianjun Zhang2B, Xinguo Li1C, Hongbing Bao1D, Guang Li1E, Ning Li1F, Hengli Li1F*, Jian Dou3GDOI: 10.12659/MSM.926760
Med Sci Monit 2021; 27:e926760
Table 1 Association of CDC20 gene expression with clinicopathologic features of HCC patients.
| Features | No. N=139 | CDC20 expression | P-values | |
|---|---|---|---|---|
| Low (n=65) | High (n=74) | |||
| Age (years) | ||||
| <60 | 69 | 34 | 35 | 0.556 |
| ≥60 | 70 | 31 | 39 | |
| Sex | ||||
| Men | 74 | 33 | 41 | 0.585 |
| Women | 65 | 32 | 33 | |
| Tumor size | ||||
| <5 cm | 62 | 30 | 32 | 0.731 |
| ≥5 cm | 77 | 35 | 42 | |
| Differentiation | ||||
| High | 60 | 43 | 17 | <0.001 |
| Low-moderate | 79 | 22 | 57 | |
| Tumor node metastasis stage | ||||
| I–II | 59 | 40 | 19 | <0.001 |
| III–IV | 80 | 25 | 55 | |
| Lymphatic metastasis | ||||
| Yes | 73 | 23 | 50 | <0.001 |
| No | 66 | 42 | 24 | |






